Brought to you by 
J&J buys Cordis, builds force in vascular disease management
09 Nov 2001
Executive Summary
Johnson & Johnson made a $1.6 billion hostile tender offer for Cordis (angiography and other coronary devices) at $100/share cash. J&J says it will cancel the takeover in favor of a negotiated stock-for-stock merger worth $1.7bn if Cordis accepts.
Deal Industry
-
Medical Devices
- Diagnostic Imaging Equipment & Supplies
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
J&J buys Cordis, builds force in vascular disease management
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice